Target intelligence / Profile preview

Chaperonin containing TCP1 subunit 7 pseudogene 2 (CCT7P2)

Target
CCT7P2
Molecular classification
Other (Pseudogene)
01

Overview

Chaperonin containing TCP1 subunit 7 pseudogene 2 (CCT7P2) is classified as a pseudogene derived from the functional gene CCT7, which encodes a subunit of the chaperonin containing TCP1 complex (TRiC/CCT)[1][4]. As a pseudogene, CCT7P2 is not known to produce a functional protein, and there is no evidence supporting its role as a therapeutic target, receptor, enzyme, transporter, or any other type of druggable entity[1][4]. Its main designation in scientific databases is as a non-coding, inactive gene segment related to the active CCT7 gene, which is involved in protein folding and cellular chaperone processes[1][4]. There is no documentation linking CCT7P2 specifically to diseases, drug interactions, or use as a biomarker. Additional notes: - The functional, protein-coding counterpart, CCT7, is involved in protein folding (via the TRiC complex) and associated with various cell processes, and diseases, but CCT7P2 itself—being a pseudogene—does not have such roles[5][6][7]. - Because it is a pseudogene, there is no established therapeutic mechanism or safety profile, and it is not a focus of drug targeting in current biomedical research[1][4].

Other names
CCT7-1Pchaperonin containing TCP1, subunit 7 (eta) pseudogene 2CCT7P2

Beyond the preview

Go deeper on Chaperonin containing TCP1 subunit 7 pseudogene 2 (CCT7P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chaperonin containing TCP1 subunit 7 pseudogene 2 (CCT7P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call